These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2411566)

  • 41. Comparative study on the combined effects of bunazosin and nipradilol or timolol on intraocular pressure in normotensive rabbits.
    Orihashi M; Shima Y; Tsuneki H; Kimura I
    Jpn J Ophthalmol; 2005; 49(6):523-526. PubMed ID: 16365801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular effects of ophthalmic timolol.
    Leier CV; Baker ND; Weber PA
    Ann Intern Med; 1986 Feb; 104(2):197-9. PubMed ID: 3946944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
    Schuman JS
    Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
    Seibold LK; DeWitt PE; Kroehl ME; Kahook MY
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):161-169. PubMed ID: 28129020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of simple chronic glaucoma.
    Mills KB
    Br J Ophthalmol; 1983 Apr; 67(4):216-9. PubMed ID: 6338905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Timolol and epinephrine: long-term evaluation of concurrent administration.
    Korey MS; Hodapp E; Kass MA; Goldberg I; Gordon M; Becker B
    Arch Ophthalmol; 1982 May; 100(5):742-5. PubMed ID: 7044351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Smith LN; Miller PE; Felchle LM
    Am J Vet Res; 2010 Sep; 71(9):1055-61. PubMed ID: 20807145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double-masked comparison of carteolol and timolol in ocular hypertension.
    Scoville B; Mueller B; White BG; Krieglstein GK
    Am J Ophthalmol; 1988 Feb; 105(2):150-4. PubMed ID: 3277436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental studies with timolol: a new ocular hypotensive agent (author's transl)].
    Vareilles P; Schmitt C; Lotti VJ; Le Douarec JC
    J Fr Ophtalmol; 1978 Dec; 1(12):717-21. PubMed ID: 155095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic equivalence study of two preparations of eye drops containing dorzolamide and timolol in healthy volunteers.
    Gatchev E; Petrov A; Kolev E; Hristova R; Demircheva I; Koytchev R; Richter W; Tegel F; Thyroff-Friesinger U
    Arzneimittelforschung; 2011; 61(5):282-6. PubMed ID: 21755811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of topical administration of timolol maleate on intraocular pressure and pupil size in cats.
    Wilkie DA; Latimer CA
    Am J Vet Res; 1991 Mar; 52(3):436-40. PubMed ID: 2035918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of 1.5% timolol maleate on intraocular pressure.
    Ritch R; Hargett NA; Podos SM
    Acta Ophthalmol (Copenh); 1978 Feb; 56(1):6-10. PubMed ID: 345735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of intraocular pressure and pupil size by beta-blockers and epinephrine.
    Ohrström A; Pandolfi M
    Arch Ophthalmol; 1980 Dec; 98(12):2182-4. PubMed ID: 6108756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A new beta-blocking agent in the treatment of chronic open-angle glaucoma: timolol maleate. Effect of instillation of 1 drop on the intraocular pressure].
    Demailly P; Lehner MA; Duperre J
    J Fr Ophtalmol; 1978 Dec; 1(12):723-6. PubMed ID: 155096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
    Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
    Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of two weeks of timolol maleate treatment on the normal retinal circulation.
    Grunwald JE
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):39-45. PubMed ID: 1987105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension.
    Larsson LI
    Ophthalmology; 2001 Aug; 108(8):1439-44. PubMed ID: 11470697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular effects of epinephrine and dipivefrin in patients using timolol: a single-dose study.
    Blondeau P; Côté M
    Can J Ophthalmol; 1984 Feb; 19(1):29-32. PubMed ID: 6713266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the ocular hypotensive effect of 0.025% bromocriptine and 0.25% timolol eye drops in normal human volunteers.
    al-Sereiti MR; Coakes RL; O'Sullivan DP; Turner P
    Br J Clin Pharmacol; 1989 Oct; 28(4):443-7. PubMed ID: 2590602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.